BDSX Q2 2023 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q2 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$12M+8.4% YoY

Gross Profit

$9M72.7% margin

Operating Income

-$11M-92.0% margin

Net Income

-$13M-112.5% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+31.1%

Cash Flow

Operating Cash Flow

$937,000

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$78M

Total Liabilities

$85M

Stockholders' Equity

-$7M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$11M	+8.4%
Gross Profit	$9M	$7M	+23.9%
Operating Income	-$11M	-$12M	+6.0%
Net Income	-$13M	-$16M	+15.6%

Revenue Segments

Diagnostic Tests

$11M96%

Service

$423,0004%